Office of the Director, National Institutes of Health; Notice of Meeting, 14574 [E9-7200]

Download as PDF 14574 Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings tjames on PRODPC61 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Regulation of Cytokine Transcription and Inflammation. Date: March 30, 2009. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3119, 6700B Rockledge Drvie, MSC–7616, Bethesda, MD 20892–7616, 301–496–7042, sundstromj@niaid.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; B Cell Epitope Discovery and Mechanisms of Antibody Protection. Date: April 20–21, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: The Legacy Hotel and Meeting Centre, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Quirijn Vos, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–451– 2666, qvos@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Rapid HIV Point-of-Care Diagnostic Device for Resource-Limited Setting. Date: April 20–21, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. VerDate Nov<24>2008 14:35 Mar 30, 2009 Jkt 217001 Place: Doubletree Hotel and Executive Meeting Center, 8120 Wisconsin Ave, Bethesda, MD 20814. Contact Person: Roberta Binder, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Room 3130, Bethesda, MD 20892– 7616, 301–496–7966, rbinder@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Ancillary Studies in Immunomodulation Clinical Trials. Date: April 24, 2009. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–7098, pamstad@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 25, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–7197 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Scientific Management Review Board. The NIH Reform Act of 2006 (Pub. L. 109–482) provides organizational authorities to HHS and NIH officials to: (1) Establish or abolish national research institutes; (2) reorganize the offices within the Office of the Director, NIH, including adding, removing, or transferring the functions of such offices or establishing or terminating such offices; and (3) reorganize, divisions, centers, or other administrative units within an NIH national research institute or national center including adding, removing, or transferring the functions of such units, or establishing or terminating such units. The purpose of the Scientific Management Review Board (also referred to as SMRB or Board) is to advise appropriate HHS and NIH officials on the use of these PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 organizational authorities and identify the reasons underlying the recommendations. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Scientific Management Review Board. Date: April 27–28, 2009. Open: April 27, 2009, 8:30 a.m. to 5:30 p.m. Agenda: Presentation and discussion will include an overview of NIH mission, structure, budget, perspectives on how science has shaped the NIH organization, and future directions. There will also be time allotted on the agenda for public comment. Sign up for public comment will begin at approximately 8 a.m. on both April 27 and 28. In the event that time does not allow for all those interested to present oral comments, anyone may file written comments using the address below. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Open: April 28, 2009, 8:30 a.m. to 3:30 p.m. Agenda: Continuation of April 27th meeting. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Contact Person: Dr. Lyric Jorgenson, PhD, NIH–AAAS Science and Technology Policy Fellow, Office of Science Policy, Office of the Director, NIH, National Institutes of Health, Building 1 Room 218 MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892. smrb@mail.nih.gov. (301) 496–6837. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. The meeting will also be Web cast. The draft meeting agenda and other information about the SMRB, including information about access to the Web cast, will be available at https://smrb.od.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: March 25, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–7200 Filed 3–30–09; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\31MRN1.SGM 31MRN1

Agencies

[Federal Register Volume 74, Number 60 (Tuesday, March 31, 2009)]
[Notices]
[Page 14574]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7200]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH, including adding, removing, or 
transferring the functions of such offices or establishing or 
terminating such offices; and (3) reorganize, divisions, centers, or 
other administrative units within an NIH national research institute or 
national center including adding, removing, or transferring the 
functions of such units, or establishing or terminating such units. The 
purpose of the Scientific Management Review Board (also referred to as 
SMRB or Board) is to advise appropriate HHS and NIH officials on the 
use of these organizational authorities and identify the reasons 
underlying the recommendations.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Scientific Management Review Board.
    Date: April 27-28, 2009.
    Open: April 27, 2009, 8:30 a.m. to 5:30 p.m.
    Agenda: Presentation and discussion will include an overview of 
NIH mission, structure, budget, perspectives on how science has 
shaped the NIH organization, and future directions. There will also 
be time allotted on the agenda for public comment. Sign up for 
public comment will begin at approximately 8 a.m. on both April 27 
and 28. In the event that time does not allow for all those 
interested to present oral comments, anyone may file written 
comments using the address below.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Open: April 28, 2009, 8:30 a.m. to 3:30 p.m.
    Agenda: Continuation of April 27th meeting.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Dr. Lyric Jorgenson, PhD, NIH-AAAS Science and 
Technology Policy Fellow, Office of Science Policy, Office of the 
Director, NIH, National Institutes of Health, Building 1 Room 218 
MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892. 
smrb@mail.nih.gov. (301) 496-6837.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The meeting will also be Web cast. The draft meeting agenda and 
other information about the SMRB, including information about access 
to the Web cast, will be available at https://smrb.od.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7200 Filed 3-30-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.